Effect of baseline dyskinesia on safety and efficacy of istradefylline, an A2A receptor antagonist, in Parkinson's disease: 8-study pooled analysis. (October 2020) - Truong, D.; Hattori, N.; Isaacson, S.H.; Rascol, O.; Mori, A.; Toyama, K.; Parno, J.; Salzman, P.M.; Ristuccia, R.; Stocchi, F.